About Toxnet
Toxnet is a global network of leading experts and specialists in the management of spasticity (including botulinum toxin treatment) that started in 2016. The Toxnet group currently consists of 21 active members with almost 450 years of collective experience (range 13-31 years; average 21.71 years).
They have been faculty members of various symposia and have published a significant amount of scientific literature in the field of spasticity and movement disorders. Their published work includes a consensus on optimization of post-stroke spasticity interventions with Botulinum Toxin, evaluation of spasticity patients using telemedicine, and an opinion paper on the role of physical and rehabilitation medicine in the COVID-19 Pandemic. Toxnet has also published a comprehensive curriculum to standardize education for clinicians in the field of post-stroke spasticity.
Why We Do It
The Toxnet group aims to be at the forefront of education, clinical innovation, and research in spasticity, and related disorders, to inspire and guide clinicians for the ultimate benefit of their patients.
Toxnet members are passionate about sharing their knowledge and expertise with other healthcare professionals to improve patient care. Toxnet members are committed to advancing research in this field and sharing their findings with the broader medical community.
To achieve this goal, Toxnet members regularly participate in international congresses and work on a number of projects for publication.
Toxnet Group Structure
The Toxnet group operates within a structured framework that accommodates up to 25 active participants. The group is divided into fluid sub-groups, as required, for specific projects. Since 2023, there have been three distinct sub-groups dedicated to education, research, and clinical innovation. This approach allows for a dynamic and collaborative environment, fostering the pursuit of knowledge and advancement in various domains within the Toxnet group.
Education
Delivery of educational initiatives including publications and symposia
Research
Delivery of research-based projects such as investigator-initiated studies
Clinical innovation
Delivery of value-added projects for the spasticity community